Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015)

This report describes linezolid susceptibility testing results for 6,741 Gram-positive pathogens from 60 U.S. sites collected during 2015 for the LEADER Program. In addition, the report summarizes linezolid in vitro activity, resistance mechanisms, and molecular typing obtained for 2011 to 2015. Dur...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Pfaller, Michael A., Mendes, Rodrigo E., Streit, Jennifer M., Hogan, Patricia A., Flamm, Robert K.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2017
Assuntos:
Epidemiology and Surveillance
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487612/
https://ncbi.nlm.nih.gov/pubmed/28483950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00609-17
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares